The role of flow cytometry in myelodysplastic syndromes

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 6, Issue 9, 2008, Pages 935-941

  Loken, Michael R ^a   Wells, Denise A ^a  

^a HEMATOLOGICS INC   (United States)

Author keywords

CD45 gating; Erythroid; Flow cytometry; Immunophenotyping; Monocyte; Multidimensional analysis; Myeloblast; Myelodysplasia; Myeloid; Stem cell

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; GENE PRODUCT; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLAST; BLOOD CELL COUNT; BONE MARROW CELL; CANCER SURVIVAL; CELL DAMAGE; CELL LINEAGE; CELL LOSS; CELL MATURATION; CELL POPULATION; CELL STRUCTURE; CELL SURFACE; CLINICAL TRIAL; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DOWN REGULATION; ERYTHROID CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; MALIGNANT TRANSFORMATION; MEGAKARYOCYTE; MONOCYTE; MYELOBLAST; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PHENOTYPE; PROGNOSIS; REFRACTORY ANEMIA; REGULATORY MECHANISM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; UPREGULATION; WORLD HEALTH ORGANIZATION;

EID: 56049125500     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2008.0071     Document Type: Article

References (40)

1. Loken M, Terstappen LWMM, Civin CI, Fackler, MJ. Flow cytometric characterization of erythroid, lymphoid and monomyeloid lineages in normal human bone marrow. In: Laerum OD, Bjerksnes R. eds. Flow Cytometry in Hematology. New York: Academic Press; 1992:31-42.
2. Loken MR, Wells DA. Normal antigen expression in hematopoiesis: basis for interpreting leukemia phenotypes. In: Nicholson J, Stewart C, eds. Immunophenotyping. New York: Wiley-Liss, Inc.; 2000: 133-160.
3. Hedge SP, Kumar A, Kurschner C, Shapiro LH. c-Maf interacts with c-Myb to regulate transcription of an early myeloid gene during differentiation. Mol Cell Biol 1998;18:2729-2737.
4. Parker D, Rivera M, Zor T, et al. Role of secondary structure in discrimination between constitutive and inducible activators. Mol Cell Biol 1999;19:5601-5607.
5. Terstappen LW, Safford M, Loken MR. Flow cytometric analysis of human bone marrow. III: neutrophil maturation. Leukemia 1990;4:657-663.
6. Terstappen LWMM, Segers-Nolten I, Safford M, et al. Monomyeloid cell differentiation in normal bone marrow assessed by multidimensional flow cytometry. In: Burger G, Oberholzer M, Vooijs GP, eds. Advances in Analytical Cellular Pathology. Amsterdam: Excerpta Medica; 1990:211-212.
7. Shulman HM, Wells D, Gooley T, et al. The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry. Am J Clin Pathol 1999;112:513-523.
8. Terstappen LW, Konemann S, Safford M, et al. Flow cytometric characterization of acute myeloid leukemia. Part 1: significance of light scattering properties. Leukemia 1991;5:315-321.
9. Hurwitz CA, Loken MR, Graham ML, et al. Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 1988;72:299-307.
10. Terstappen LW, Safford M, Konemann S, et al. Flow cytometric characterization of acute myeloid leukemia. Part II: phenotypic heterogeneity at diagnosis. Leukemia 1992;6:70-80.
11. Terstappen LW, Loken MR. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol 1990;2:229-240.
12. Bowen KL, Davis, BH Abnormal patterns of expression of CD16 (FcR-III) and CD11b (CRIII) in the bone marrow of patients with myelodysptastic syndrome. Lab Hematol 1997;3:292-298.
13. Kussick SJ, Fromm JR, Rossini A, et al. Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Am J Clin Pathol 2005;124:170-181.
14. Loken MR, van de Loosdrecht A, Ogata K, et al. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 2008;32:5-17.
15. Malcovati L, Delta Porta MG, Lunghi M, et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005;19:776-783.
16. Maynadie M, Picard F, Husson B, et al. Immunophenotypic clustering of myelodysptastic syndromes. Blood 2002;100:2349-2356.
17. Ogata K, Kishikawa Y, Satoh C, et al. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006;108:1037-1044.
18. Ogata K, Nakamura K, Yokose N, et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 2002;100:3887-3896.
19. Stachurski D, Smith BR, Pozdnyakova O, et al. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res 2008;32:215-224.
20. Stetler-Stevenson M, Arthur DC, Jabbour N, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 2001;98:979-987.
21. Wells DA, Benesch M, Loken MR, et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 2003;102: 394-403.
22. van de Loosdrecht AA, Westers TM, Ossenkoppele GJ. Flowcytometry in myelodysplastic syndromes: towards a new paradigm in diagnosis and prognostication? Leuk Res 2008;32:205-207.
23. Wells DA, Ogata K. On flow cytometry in myelodysplastic syndromes, with caveats. Leuk Res 2008;32:209-210.
24. Matarraz S, Lopez A, Barrena S, et al. The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34(+) hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors. Leukemia 2008;22:1175-1183.
25. van de Loosdrecht AA, Westers TM, Westra AH, et al. Identification of distinct prognostic subgroups in low and intermediate-1 risk myelodysplastic syndromes by flow cytometry. Blood 2008;111: 1067-1077.
26. Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007;31:727-736.
27. Loken MR, Civin CI, Bigbee WL, et al. Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis. Blood 1987;70:1959-1961.
28. Loken MR, Shah VO, Dattilio KL, Civin CI. Flow cytometric analysis of human bone marrow: I. Normal crythroid development. Blood 1987;69:255-263.
29. Chen JC, Bigelow N, Davis BH. Proposed flow cytometric reference method for the determination of erythroid F-cell counts. Cytometry 2000;42:239-246.
30. Mendek-Czajkowska E, Slomkowski M, Zdebska E, et al. Hemoglobin F in primary myelofibrosis and in myelodysplasia. Clin Lab Haematol 2003;25:289-292.
31. Della Porta MG, Malcovati L, Invernizzi R, et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006;20:549-555.
32. Civin CI, Banquerigo ML, Strauss LC, Loken MR. Antigenic analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp Hematol 1987;15:10-17.
33. Strijbos MH, Kraan J, den Bakker MA, et al. Cells meeting our immunophenotypic criteria of endothelial cells are large platelets. Cytometry B Clin Cytom 2007;72:86-93.
34. Escribano L, Ocqueteau M, Almeida J, et al. Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis. Leuk Lymphoma 1998;30:459-466.
35. Haase D, Feuring-Buske M, Schafer C, et al. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Leukemia 1997;11:674-679.
36. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51: 189-199.
37. Loken M, Chu S, Fritschle W, et al. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses. Cytometry Part B (Clinical Cytometry) 2008; in press.
38. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-2088.
39. Bennett JM. World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 2000;72: 131-133.
40. Malcovati L, Germing U, Kuendgen A, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007;253503-3510.